Swiss National Bank Purchases 31,500 Shares of The Cooper Companies, Inc. $COO

Swiss National Bank boosted its position in The Cooper Companies, Inc. (NASDAQ:COO) by 5.8% during the first quarter, HoldingsChannel reports. The fund owned 575,200 shares of the medical device company’s stock after buying an additional 31,500 shares during the quarter. Swiss National Bank’s holdings in Cooper Companies were worth $41,127,000 as of its most recent filing with the SEC.

Several other institutional investors have also added to or reduced their stakes in COO. Root Financial Partners LLC boosted its position in Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after purchasing an additional 162 shares during the period. SJS Investment Consulting Inc. raised its position in shares of Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 187 shares during the period. True Wealth Design LLC lifted its stake in shares of Cooper Companies by 484.8% during the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock valued at $38,000 after buying an additional 383 shares in the last quarter. Cromwell Holdings LLC boosted its holdings in Cooper Companies by 128.8% in the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after buying an additional 273 shares during the period. Finally, CYBER HORNET ETFs LLC bought a new position in Cooper Companies in the 2nd quarter worth approximately $36,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

NASDAQ COO opened at $70.50 on Thursday. The company’s 50 day simple moving average is $66.93 and its two-hundred day simple moving average is $72.28. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The stock has a market capitalization of $13.75 billion, a PE ratio of 59.75, a P/E/G ratio of 1.86 and a beta of 0.84.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The firm had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

COO has been the topic of a number of analyst reports. Wells Fargo & Company reissued a “sell” rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a report on Friday, June 5th. Needham & Company LLC cut their price target on Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a report on Friday, June 5th. Citigroup reiterated a “neutral” rating and issued a $76.00 price target (up from $69.00) on shares of Cooper Companies in a research report on Wednesday, July 8th. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a research note on Sunday, June 21st. Finally, Stifel Nicolaus cut their target price on Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $81.85.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.